ClinicalTrials.Veeva

Menu

Validation and Standardisation of a Pool of Simplified Evaluation Aimed to the Diagnoses of Aphasic Disorders and Adapted to the Patients Suffering an Acute Phase of Stroke (BESTA-AVC)

U

University of Limoges (UL)

Status

Unknown

Conditions

Stroke

Treatments

Other: BESTA scale

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Every year in France, from 100 000 to 145 000 people are affected by a stroke. 75% patients survived with aftereffects, in particular aphasic disorders.

A sketch of a new tool called BESTA aiming to a rapid handover to the acute phase post stroke had been worked out. After a meeting, 13 multidisciplinary experts have discussed, adjusted and a new complete tool (BESTA) had been created in order to evaluate the different states of aphasia.

The goal of this study is the validation and the standardization of this new BESTA tool.

Enrollment

395 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Patients with stroke:

  • Every patient over 18,
  • admitted among neuro-vascular unit,
  • native french speaker,
  • the level of vigilance is satisfactory in order to allow a speech therapy test.

Healthy Volunteers:

  • Every volunteers over 18,
  • without any medical history of a stroke or any speech disorders,
  • native french speaker.

Exclusion criteria

Patients with stroke and Healthy Volunteers :

  • dementia disease
  • psychiatric condition
  • non-equipped deafness
  • pregnant woman
  • patient with medical histories of stroke

Trial design

395 participants in 1 patient group

BESTA scale
Description:
BESTA scale is administered at T0, T1 (3 months) and T2 (1 year)
Treatment:
Other: BESTA scale

Trial contacts and locations

1

Loading...

Central trial contact

Amandine CHANAUD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems